Femme Homme
- | Pays :
- Italy
- United Kingdom
- Germany
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary purpose of this study is to identify the maximum tolerated dose (MTD) of both intravenous and oral panobinostat plus trastuzumab. The study will evaluate safety and efficacy of the combination in adult female patients with HER2+ metastatic breast cancer
Critère d'inclusion
- Breast Cancer